Get the Stockscreener App
0.4399
5.24%
0.0219
After Hours:
.42
-0.0199
-4.52%
Promis Neurosciences Inc stock is traded at $0.4399, with a volume of 530.97K.
It is up +5.24% in the last 24 hours and down -37.16% over the past month.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
See More
Previous Close:
$0.418
Open:
$0.41
24h Volume:
530.97K
Relative Volume:
0.07
Market Cap:
$22.79M
Revenue:
-
Net Income/Loss:
$-563.30K
P/E Ratio:
-2.2039
EPS:
-0.1996
Net Cash Flow:
$-22.23M
1W Performance:
+2.30%
1M Performance:
-37.16%
6M Performance:
-42.41%
1Y Performance:
-64.81%
1-Day Range:
$0.4081
$0.4477
1-Week Range:
$0.39
$0.4477
52-Week Range:
$0.38
$1.59
Promis Neurosciences Inc Stock (PMN) Company Profile
Name
Promis Neurosciences Inc
Sector
Industry
Phone
416-847-6898
Address
SUITE 200, 1920 YONGE STREET, TORONTO
Compare PMN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMN
Promis Neurosciences Inc
|
0.4399 | 20.72M | 0 | -563.30K | -22.23M | -0.1996 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Promis Neurosciences Inc Stock (PMN) Latest News
What institutional flow reveals about ProMIS Neurosciences Inc.Market Trend Summary & Reliable Intraday Trade Plans - Newser
Will breakout in ProMIS Neurosciences Inc. lead to full recoveryWeekly Trend Report & Safe Swing Trade Setups - Newser
Relative strength of ProMIS Neurosciences Inc. in sector analysisMarket Sentiment Report & Verified Swing Trading Watchlist - Newser
Applying Wyckoff theory to ProMIS Neurosciences Inc. stockBear Alert & Fast Moving Stock Trade Plans - Newser
Using portfolio simulators with ProMIS Neurosciences Inc. included2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser
Does ProMIS Neurosciences Inc. show high probability of reboundMarket Activity Report & Advanced Swing Trade Entry Plans - Newser
Sector ETF performance correlation with ProMIS Neurosciences Inc.July 2025 Short Interest & Weekly Return Optimization Alerts - Newser
Volatility clustering patterns for ProMIS Neurosciences Inc.Market Volume Report & Capital Efficient Trade Techniques - Newser
How to track smart money flows in ProMIS Neurosciences Inc.Gap Up & Free Technical Confirmation Trade Alerts - Newser
Live market analysis of ProMIS Neurosciences Inc.Weekly Market Outlook & Momentum Based Trading Ideas - Newser
Top chart patterns to watch in ProMIS Neurosciences Inc.2025 Trading Volume Trends & Safe Entry Trade Reports - Newser
ProMIS Neurosciences Inc. stock volume spike explainedShare Buyback & Community Consensus Trade Alerts - Newser
Visualizing ProMIS Neurosciences Inc. stock with heatmapsWeekly Trade Analysis & Reliable Entry Point Alerts - Newser
Has ProMIS Neurosciences Inc. formed a bullish divergenceJuly 2025 Intraday Action & High Yield Stock Recommendations - Newser
Technical analysis overview for ProMIS Neurosciences Inc. stockTrade Volume Summary & Weekly High Momentum Picks - Newser
What’s the recovery path for long term holders of ProMIS Neurosciences Inc.2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Using economic indicators to assess ProMIS Neurosciences Inc. potentialWeekly Stock Report & Daily Profit Maximizing Tips - Newser
What MACD signals say about ProMIS Neurosciences Inc.Entry Point & Verified Short-Term Plans - Newser
Applying sector rotation models to ProMIS Neurosciences Inc.Sell Signal & AI Enhanced Trade Execution Alerts - Newser
Using Ichimoku Cloud for ProMIS Neurosciences Inc. technicalsGold Moves & Smart Swing Trading Techniques - Newser
will breakout in promis neurosciences inc. lead to full recoveryMarket Growth Review & AI Driven Price Forecasts - Newser
ProMIS Neurosciences Inc. stock trend outlook and recovery pathRisk Management & Verified Technical Signals - Newser
Market reaction to ProMIS Neurosciences Inc.’s recent newsQuarterly Risk Review & Real-Time Buy Zone Alerts - Newser
Using data tools to time your ProMIS Neurosciences Inc. exitWeekly Trade Review & Weekly Watchlist for Hot Stocks - Newser
ProMIS Neurosciences Inc. stock trend forecast2025 Momentum Check & Daily Price Action Insights - Newser
Ranking ProMIS Neurosciences Inc. among high performing stocks via toolsJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - Newser
Exit strategy if you’re trapped in ProMIS Neurosciences Inc.M&A Rumor & Long-Term Safe Investment Ideas - Newser
Using fundamentals and technicals on ProMIS Neurosciences Inc.Market Rally & AI Enhanced Execution Alerts - Newser
Multi asset correlation models including ProMIS Neurosciences Inc.July 2025 EndofMonth & Fast Exit and Entry Strategy Plans - Newser
How to manage a losing position in ProMIS Neurosciences Inc.2025 EndofYear Setup & Proven Capital Preservation Methods - Newser
promis neurosciences inc. stock volume spike explainedJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - Newser
Smart tools for monitoring ProMIS Neurosciences Inc.’s price actionIndex Update & AI Driven Price Forecasts - Newser
Is ProMIS Neurosciences Inc. stock entering bullish territory2025 Retail Activity & Accurate Buy Signal Notifications - Newser
Promis Neurosciences Inc Stock (PMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):